 | AbbVie Inc (NYSE:ABBV) Sees Significant Growth in Short Interest
www.americanbankingnews.com - September 14 at 2:49 AM |
 | AbbVie Stock Rises After UBS Upgrades To Buy - TheStreet.com
www.thestreet.com - September 13 at 1:15 PM |
 | Consumer groups, unions urge caution on $63 billion AbbVie deal for Allergan - Reuters
www.reuters.com - September 13 at 1:15 PM |
 | Buy AbbVie Stock, as Its Deal for Allergan Might Work, Analyst Says - Barron's
www.barrons.com - September 13 at 1:15 PM |
 | Anxious About AbbVie? Here Are 4 Things You Should Know - Motley Fool
www.fool.com - September 12 at 8:58 AM |
| Anxious About AbbVie? Here Are 4 Things You Should Know
www.fool.com - September 12 at 8:29 AM |
| AbbVie (NYSE:ABBV) Upgraded to "Buy" at UBS Group
www.americanbankingnews.com - September 12 at 7:33 AM |
 | AbbVie Inc. (ABBV) CEO Rick Gonzalez Presents at Morgan Stanley Healthcare Conference (Transcript) - Seeking Alpha
seekingalpha.com - September 10 at 8:48 PM |
| AbbVie: The 6.5% Yield Window Won't Stay Open Much Longer - Seeking Alpha
seekingalpha.com - September 10 at 3:48 PM |
| AbbVie Inc (NYSE:ABBV) Declares $1.07 -- Dividend
www.americanbankingnews.com - September 9 at 6:13 PM |
 | 3 Stocks to Buy With Dividends Yielding More Than 6%
finance.yahoo.com - September 8 at 8:09 AM |
| Top Stock Reports for Microsoft, Home Depot & AbbVie - Yahoo Finance
finance.yahoo.com - September 7 at 10:22 AM |
| AbbVie Declares Quarterly Dividend - Yahoo Finance
finance.yahoo.com - September 7 at 10:22 AM |
| AbbVie Inc Forecasted to Earn FY2019 Earnings of $9.04 Per Share (NYSE:ABBV)
www.americanbankingnews.com - September 6 at 6:26 AM |
| Allergan: Why I Like This AbbVie Target - Seeking Alpha
seekingalpha.com - September 6 at 5:37 AM |
| AbbVie Inc (NYSE:ABBV) SVP Nicholas Donoghoe Buys 7,525 Shares
www.americanbankingnews.com - September 4 at 5:59 PM |
 | UPDATE: Abbvie (ABBV) Dermatologist Study Puts Skyrizi on Par With Enbrel, PT to $81 at Piper Jaffray - StreetInsider.com
www.streetinsider.com - September 4 at 3:12 PM |
| Idera teams up with AbbVie in cancer combo therapies - Seeking Alpha
seekingalpha.com - September 4 at 3:12 PM |
| 3 Lessons From AbbVie's $5.8 Billion Blunder With Cancer Drug Rova-T - Yahoo Finance
finance.yahoo.com - September 4 at 3:12 PM |
| AbbVie Inc (NYSE:ABBV) Receives Average Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - September 4 at 2:47 PM |
| AbbVie (NYSE:ABBV) Price Target Increased to $81.00 by Analysts at Piper Jaffray Companies
www.americanbankingnews.com - September 4 at 11:31 AM |
| 3 Lessons From AbbVie's $5.8 Billion Blunder With Cancer Drug Rova-T - Motley Fool
www.fool.com - September 4 at 9:49 AM |
| Idera Pharmaceuticals Announces Immuno-Oncology Clinical Research Collaboration with AbbVie - Yahoo Finance
finance.yahoo.com - September 4 at 9:49 AM |
| 3 Lessons From AbbVie's $5.8 Billion Blunder With Cancer Drug Rova-T
finance.yahoo.com - September 4 at 9:49 AM |
| Idera teams up with AbbVie in cancer combo therapies
seekingalpha.com - September 4 at 8:09 AM |
| AbbVie: Even Better Dividend Now - Seeking Alpha
seekingalpha.com - September 3 at 8:03 PM |
| The Zacks Analyst Blog Highlights: J&J, Eli Lilly, Bristol-Myers, Roche and AbbVie
finance.yahoo.com - September 3 at 3:02 PM |
| Why Bank of America Says Dividend Stocks are the Only Play Now
finance.yahoo.com - September 3 at 3:02 PM |
| Brokerages Expect AbbVie Inc (NYSE:ABBV) Will Announce Quarterly Sales of $8.38 Billion
www.americanbankingnews.com - September 3 at 5:12 AM |
| 3 High-Yield Dividend Stocks to Buy on Sale
finance.yahoo.com - September 1 at 4:12 PM |
| Analysts Anticipate AbbVie Inc (NYSE:ABBV) to Announce $2.28 EPS
www.americanbankingnews.com - September 1 at 2:20 AM |
| AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails - Yahoo Finance
finance.yahoo.com - August 30 at 8:27 PM |
 | Big Pharma kills signature drug at center of $5.8 billion South S.F. deal - San Francisco Business Times
www.bizjournals.com - August 30 at 8:27 PM |
 | AbbVie is shutting down its troubled Rova-T R&D program - MarketWatch
www.marketwatch.com - August 30 at 8:27 PM |
 | AbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung Cancer
www.msn.com - August 30 at 3:20 PM |
 | AbbVie Ends Work on Drug From $5.8 Billion Deal After Failures
www.bloomberg.com - August 30 at 3:20 PM |
| Pharma Stock Roundup: JNJ's Opioid Lawsuit, Regulatory Nod for LLY, BMY, RHHBY Drugs
finance.yahoo.com - August 30 at 11:39 AM |
| AbbVie Ends Rova-T Program as 3rd Lung Cancer Study Fails
finance.yahoo.com - August 30 at 11:39 AM |
| FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to... - Reuters
www.reuters.com - August 29 at 8:08 PM |
| AbbVie Ends Work on Drug From $5.8 Billion Deal After Failures - Bloomberg
www.bloomberg.com - August 29 at 8:08 PM |
| AbbVie Discontinues Phase III Trial of Drug to Treat Small-Cell Lung Cancer - TheStreet.com
www.thestreet.com - August 29 at 3:06 PM |
| Should You Buy AbbVie for the Dividend? - Yahoo Finance
finance.yahoo.com - August 29 at 3:06 PM |
| AbbVie bails on ADC Rova-T in lung cancer - Seeking Alpha
seekingalpha.com - August 29 at 9:33 AM |
| UPDATE 1-FDA flags risks from AbbVie, Gilead, Merck hepatitis C drugs to certain patients
finance.yahoo.com - August 29 at 9:33 AM |
| AbbVie Discontinues Rovalpituzumab Tesirine (Rova-T) Research and Development Program
finance.yahoo.com - August 29 at 9:33 AM |
| AbbVie terminates late-stage lung cancer trial
finance.yahoo.com - August 29 at 9:33 AM |
| AbbVie is shutting down its troubled Rova-T R&D program
finance.yahoo.com - August 29 at 9:33 AM |
| AbbVie Shareholders Can Earn 17% On Excess Cash Through Merger Arbitrage - Seeking Alpha
seekingalpha.com - August 28 at 3:08 PM |
 | BARCLAYS PLC UK Regulatory Announcement: Form 8.3 - ABBVIE INC - Business Wire
www.businesswire.com - August 28 at 11:51 AM |
| Bristol-Myers' Empliciti Gets EMA Nod for Label Expansion
finance.yahoo.com - August 28 at 11:51 AM |
